- Home
- AQST vs CYD Comparison
AQST vs CYD Comparison
Compare AQST & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- CYD
- Stock Information
- Founded
- AQST 2004
- CYD 1951
- Country
- AQST United States
- CYD Singapore
- Employees
- AQST N/A
- CYD N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- CYD Industrial Machinery/Components
- Sector
- AQST Health Care
- CYD Industrials
- Exchange
- AQST Nasdaq
- CYD Nasdaq
- Market Cap
- AQST 502.6M
- CYD 493.2M
- IPO Year
- AQST 2018
- CYD 1994
- Fundamental
- Price
- AQST $4.41
- CYD $9.05
- Analyst Decision
- AQST Strong Buy
- CYD
- Analyst Count
- AQST 7
- CYD 0
- Target Price
- AQST $9.43
- CYD N/A
- AVG Volume (30 Days)
- AQST 1.7M
- CYD 18.1K
- Earning Date
- AQST 11-04-2024
- CYD 08-12-2024
- Dividend Yield
- AQST N/A
- CYD 4.20%
- EPS Growth
- AQST N/A
- CYD 14.53
- EPS
- AQST N/A
- CYD 1.17
- Revenue
- AQST $58,900,000.00
- CYD $2,639,608,357.00
- Revenue This Year
- AQST $18.45
- CYD $11.68
- Revenue Next Year
- AQST N/A
- CYD $4.06
- P/E Ratio
- AQST N/A
- CYD $7.73
- Revenue Growth
- AQST 22.56
- CYD 15.32
- 52 Week Low
- AQST $1.69
- CYD $7.85
- 52 Week High
- AQST $6.23
- CYD $13.05
- Technical
- Relative Strength Index (RSI)
- AQST 37.69
- CYD 12.61
- Support Level
- AQST $4.62
- CYD $9.05
- Resistance Level
- AQST $5.59
- CYD $11.80
- Average True Range (ATR)
- AQST 0.37
- CYD 0.42
- MACD
- AQST -0.11
- CYD -0.26
- Stochastic Oscillator
- AQST 2.54
- CYD 0.95
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About CYD China Yuchai International Limited
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.